EYEGATE PHARMACEUTICALS INC has a total of 25 patent applications. Its first patent ever was published in 2008. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets medical technology, pharmaceuticals and optics are SOOFT ITALIA SPA, NITRIC BIOTHERAPEUTICS INC and RADIATION BARRIER LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Australia | 4 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | Canada | 3 | |
#6 | China | 2 | |
#7 | Brazil | 1 | |
#8 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals | |
#3 | Optics | |
#4 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Electrotherapy | |
#3 | Implantable devices | |
#4 | Therapeutic chemical compounds | |
#5 | Spectacles | |
#6 | Nanostructure applications |
# | Name | Total Patents |
---|---|---|
#1 | Manzo Michael | 10 |
#2 | Moslemy Peyman | 9 |
#3 | Schubert William | 6 |
#4 | Patane Michael | 5 |
#5 | Jaffe Mike | 4 |
#6 | Isom William | 4 |
#7 | Cook Gary | 4 |
#8 | Wang Hong | 4 |
#9 | Calias Perry | 4 |
#10 | Patane Mike | 3 |
Publication | Filing date | Title |
---|---|---|
WO2020227002A1 | Compositions and methods for treatment of ocular diseases | |
AU2016209028A1 | Iontophoretic contact lens | |
WO2011041377A1 | Ocular iontophoresis of charged micelles containing bioactive agents | |
WO2011041373A1 | Positively-charged poly (d,l-lactide-co-glycolide) nanoparticles and fabrication methods of the same | |
CN102341146A | System and method for ocular iontophoresis with buffering | |
WO2010009087A1 | Iontophoretic delivery of a controlled-release formulation in the eye | |
AU2009219426A1 | Enhanced delivery of a therapeutic to ocular tissues through iontophoresis |